Hilltop Partners’s Elevance Health ELV Stock Holding History

Hilltop Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Sell	907 -7	-0.8%	-$2.6K	0.09%	102
2026 Q1	$268K	Buy	914 +45	+5%	+$14.8K	0.07%	104
2025 Q4	$305K	Hold	869	–	–	0.08%	94
2025 Q3	$281K	Hold	869	–	–	0.08%	95
2025 Q2	$338K	Buy	869 +40	+5%	+$16.1K	0.1%	84
2025 Q1	$361K	Buy	829 +3	+0.4%	+$1.2K	0.12%	78
2024 Q4	$305K	Hold	826	–	–	0.1%	80
2024 Q3	$430K	Sell	826 -70	-8%	-$37.4K	0.14%	73
2024 Q2	$486K	Hold	896	–	–	0.18%	66
2024 Q1	$465K	Sell	896 -4	-0.4%	-$1.99K	0.17%	70
2023 Q4	$424K	Buy	900 +9	+1%	+$4.16K	0.17%	68
2023 Q3	$388K	Hold	891	–	–	0.16%	69
2023 Q2	$396K	Buy	891 +7	+0.8%	+$3.23K	0.16%	66
2023 Q1	$406K	Hold	884	–	–	0.18%	47
2022 Q4	$453K	Buy	+884	New	+$449K	0.24%	32

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hilltop Partners's ELV Position: Q2 2026 in Review

Hilltop Partners reduced its Elevance Health (ELV) stake by 0.77% in Q2 2026, selling an estimated $2.6K and leaving 907 shares worth $351K. The position accounts for 0.09% of the portfolio, ranked #102.

Hilltop Partners first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $486K in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Hilltop Partners held 907 shares of Elevance Health worth $351K as of Q2 2026.
Hilltop Partners sold 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
Elevance Health made up 0.09% of Hilltop Partners's portfolio in Q2 2026, its #102 holding.
Hilltop Partners first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
Hilltop Partners's Elevance Health position peaked at $486K in Q2 2024.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hilltop Partners's 13F filing for Q2 2026, filed 5 Aug 2026.